Ipratropium Bromide Solution
Product Images NDC 47335-706

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 47335-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

FDA Label Image

Figure-2 (Figure 2)

FDA Label Image

Figure-3 (Figure 3)

FDA Label Image

Snowbox 1

Snowbox  1
This text contains information about a medication called Ipratropium Bromide Inhalation Solution, which is used for oral inhalation only. It is available in unit-dose vials with a certain concentration of active ingredients. The product comes with patient instructions for use and should be stored in certain conditions. The manufacturer and distributor of the product are also mentioned.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Ipratropium bromide is a medication used for the treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). Its chemical formula is CyoHzBrNO,*H,0 and its molecular weight is 430.4 g/mol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.